Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Aponvie™ (aprepitant) – New drug approval
September 16, 2022 - Heron Therapeutics announced the FDA approval of Aponvie (aprepitant) injectable emulsion, for the prevention of postoperative nausea and vomiting (PONV) in adults.
